Webinar: Wharton Women on Healthcare Boards - Lessons from the Front Lines

Research has shown that having gender-diverse boards is positively correlated with better financial and non-financial performance, contributing to overall company growth and Environmental, Social, and Governance (“ESG”) performance. Join us for this special event to hear from three highly successful Wharton women executives who have served on a variety of types of healthcare boards and learn from their experience as company directors. Topics to be addressed include, but will not be limited to:   

1. What it is really like to serve on a healthcare board
2. Why you should consider board service and what it takes to get there
3. Potential pitfalls to avoid when joining a board
4. Key issues currently facing healthcare company boards 

Our Organizer and Moderator:

Anne-Maree Cantwell, MD, MBA
Anne-Maree is currently a Venture Partner at Empactful Capital, a venture firm investing in digital healthcare. Prior to that, she was an Internist for over 20 years at Kaiser Permanente in Northern California where she worked as both a hospitalist and as a primary care physician. In 2016, Anne-Maree launched the telemedicine practice at her medical center increasing video visits from 1% of all encounters to 30% over a 5-year period. Anne-Maree received her MBA from the Lauder Institute at the Wharton School and worked in investment and corporate banking internationally and domestically for 6 years prior to going to medical school. 

Our Esteemed Panelists: 

Stacey Seltzer

Stacey Seltzer is a Partner with Gurnet Point Capital (GPC) which she joined in 2022. Prior to joining GPC, Stacey was a Partner at Aisling Capital where she invested in life sciences companies.  Over the course of her 14 years at Aisling, Stacey’s board service included Agile Therapeutics, Aimmune Therapeutics (acquired by Nestle Health), AVROBIO, Durata Therapeutics (acquired by Actavis), Miramar Labs (acquired by Sientra), Promentis Pharmaceuticals, Prolacta Bioscience, Spruce Biosciences, and ZELTIQ Aesthetics (acquired by Allergan).  Stacey currently serves as a director of Reneo Pharmaceuticals.  

Maureen Spivack

Maureen Spivack serves as Non-Executive Chairwoman of the Board of Excelin Health, a Home Health and Hospice Services provider, and a Corinthian portfolio company. She joined the company’s board in 2018 and was named chairwoman in 2022. 

As executive advisor to Corinthian Capital, she provides valuable insight and expertise for sourcing opportunities and evaluating acquisitions in the healthcare industry. Maureen also served as the past Chairperson of the Board of Community Health Accreditation Partner (CHAP), the national accreditation body for community-based healthcare. 

Barbara Troupin

Barbara Troupin is a serial Chief Medical Officer, startup/C-suite/VC advisor, and public-company independent board director. She currently sits on the Board and is a member of the Nomination and Governance Committee for Equillium Bio (NASDAQ:EQ). Over her 20+ years as a life science executive, her roles have spanned Clinical, Medical, Regulatory, Operations and Strategy functional areas, and she has worked at both private and public companies. Barbara is a member of Athena Alliance, a group that promotes board service among women, and where she runs a monthly peer group of Women in Life Sciences.